RNA in situ hybridization
    1.
    发明授权
    RNA in situ hybridization 有权
    RNA原位杂交

    公开(公告)号:US09051610B2

    公开(公告)日:2015-06-09

    申请号:US12993338

    申请日:2009-05-19

    摘要: A method for identifying the presence of a target gene mRNA is provided, which involves hybridizing one or more oligonucleic acid probes with the target gene mRNA expressed in a tissue sample, and detecting a low-molecular-weight compound label added to at least one of the bases of the oligonucleic acid probes. The oligonucleic acid probes are contacted with the tissue sample for hybridization with the target gene mRNA after pretreating (prehybridizing) one or more dummy oligonucleic acids with the tissue sample, or a mixture of the oligonucleic acid probes and the dummy oligonucleic acids is contacted with the sample tissue to hybridize the oligonucleic acid probes with the target gene mRNA.

    摘要翻译: 提供了鉴定靶基因mRNA的存在的方法,其包括将一种或多种寡核酸探针与组织样品中表达的靶基因mRNA杂交,以及检测添加到以下各项中的至少一种的低分子量化合物标记: 寡核酸探针的碱基。 在组织样品预处理(预杂交)一种或多种模拟寡核酸之后,将寡核酸探针与组织样品接触以与靶基因mRNA杂交,或者将寡核酸探针和虚拟寡核酸的混合物与 样品组织将寡核酸探针与靶基因mRNA杂交。

    RNA IN SITU HYBRIDIZATION
    2.
    发明申请
    RNA IN SITU HYBRIDIZATION 有权
    RNA in SITU HYBRIDIZATION

    公开(公告)号:US20110183331A1

    公开(公告)日:2011-07-28

    申请号:US12993338

    申请日:2009-05-19

    IPC分类号: C12Q1/68

    摘要: Disclosed is a method for identifying the presence of a target gene mRNA, which comprises hybridizing one or more oligonucleic acid probes with the target gene mRNA expressed in a tissue sample, and detecting a low-molecular-weight compound label added to at least one of the bases of the oligonucleic acid probes, wherein the oligonucleic acid probes are contacted with the tissue sample for hybridization with the target gene mRNA after pretreating (prehybridizing) one or more dummy oligonucleic acids with the tissue sample, or a mixture of the oligonucleic acid probes and the dummy oligonucleic acids is contacted with the sample tissue to hybridize the oligonucleic acid probes with the target gene mRNA, and wherein the dummy oligonucleic acids are substantially equal in length with the oligonucleic acid probes, and are neither hybridizable with regions of the target gene mRNA with which the oligonucleic acid probes hybridize nor with the oligonucleic acid probes.

    摘要翻译: 公开了一种鉴定目标基因mRNA的存在的方法,其包括将一种或多种寡核酸探针与组织样品中表达的靶基因mRNA杂交,并检测添加到以下的至少一种的低分子量化合物标记: 寡核酸探针的碱基,其中寡聚核酸探针与组织样品接触,用于与组织样品预处理(预杂交)(预杂交)一种或多种假寡聚核酸或寡核酸探针的混合物与靶基因mRNA杂交 使虚拟寡核酸与样品组织接触,将寡核酸探针与靶基因mRNA杂交,并且其中虚拟寡核酸与寡核酸探针的长度基本相等,并且不与靶基因的区域杂交 寡聚核酸探针与其杂交的mRNA也不与低聚核酸探针杂交。

    Mutant PCNA
    3.
    发明授权
    Mutant PCNA 有权
    突变型PCNA

    公开(公告)号:US08003346B2

    公开(公告)日:2011-08-23

    申请号:US11994437

    申请日:2006-07-04

    IPC分类号: G01N33/52 C07H17/00 C07K14/00

    摘要: The present invention is to construct a DNA replication reaction system which is excellent in versatility and is easily used. An amino acid sequence of a PCNA monomer which is one of factors involved in DNA replication is prepared so that amino acid residues causing mutual charge repulsion constitute a site which causes, when an N terminal region of the PCNA monomer and a C terminal region of another PCNA monomer act as an interface to form a multimeric complex, an intermolecular interaction of the monomers in an interface region of the monomers.

    摘要翻译: 本发明是构建通用性优异且易于使用的DNA复制反应体系。 制备作为涉及DNA复制的因素之一的PCNA单体的氨基酸序列,使得导致相互电荷排斥的氨基酸残基构成了当PCNA单体的N末端区域和另一个的C末端区域时引起的位点 PCNA单体作为形成多聚体复合物的界面,单体在界面区域中的分子间相互作用。

    ACTUATOR
    4.
    发明申请
    ACTUATOR 失效
    执行机构

    公开(公告)号:US20100231070A1

    公开(公告)日:2010-09-16

    申请号:US12305872

    申请日:2007-04-19

    IPC分类号: H02K7/06

    CPC分类号: H02K7/06

    摘要: An actuator having an output axis which is moved linearly by a rotatory force, and a boss for holding the above-mentioned output axis in such a way that the output axis can move linearly includes a connecting member for propagating the linear motion of the above-mentioned output axis to an external device. The above-mentioned connecting member is comprised of a joint connected to the above-mentioned output axis, and a link plate having an end rotatably connected to the above-mentioned joint, and another end rotatably connected to the external device. A mechanism for preventing rotation of the above-mentioned output axis is constructed of only a connecting portion for connecting the above-mentioned joint, the above-mentioned link plate, and the above-mentioned external device to one another.

    摘要翻译: 具有通过旋转力线性移动的输出轴的致动器和用于保持上述输出轴线的凸起,使得输出轴线性线性地移动,具有用于传播上述输出轴的直线运动的连接部件, 提到的输出轴到外部设备。 上述连接构件包括连接到上述输出轴线的接头和具有可旋转地连接到上述接头的端部的连接板,以及可旋转地连接到外部设备的另一端。 用于防止上述输出轴的旋转的机构仅由用于将上述接头,上述连接板和上述外部装置彼此连接的连接部分构成。

    Interaction inhibitors, method of detecting interaction inhibitor and kit detecting interaction inhibitor
    5.
    发明申请
    Interaction inhibitors, method of detecting interaction inhibitor and kit detecting interaction inhibitor 审中-公开
    相互作用抑制剂,相互作用抑制剂检测方法和试剂盒检测相互作用抑制剂

    公开(公告)号:US20070134663A1

    公开(公告)日:2007-06-14

    申请号:US10568578

    申请日:2004-08-13

    IPC分类号: C12Q1/68 C12Q1/48 C12N9/99

    摘要: The task is to provide protein interaction inhibitors and/or detection method for interaction inhibitors related to regulation of T cell activation and production of IL-2. The present invention provides inhibitors of interaction between PKC theta and KPNA1, and inhibitors of interaction between KPNA1 and NF-kappaB. Inhibitors of interaction is defined as an candidate compound demonstrating the inhibition of interaction by assaying whether interaction has occurred or not between 2 types of protein and the candidate compound under the conditions allowing interaction of each combination. The detection kit is equipped with samples providing proteins of combinations to be interacted.

    摘要翻译: 任务是提供蛋白质相互作用抑制剂和/或与调节T细胞活化和产生IL-2相关的相互作用抑制剂的检测方法。 本发明提供PKCθ与KPNA1之间相互作用的抑制剂,以及KPNA1与NF-κB之间相互作用的抑制剂。 相互作用的抑制剂被定义为通过测定在允许每种组合的相互作用的条件下,在两种类型的蛋白质和候选化合物之间是否发生相互作用来证明相互作用的抑制的候选化合物。 检测试剂盒配备提供待相互作用的组合蛋白质的样品。

    Electrical actuator
    6.
    发明授权

    公开(公告)号:US07053510B2

    公开(公告)日:2006-05-30

    申请号:US10118904

    申请日:2002-04-10

    申请人: Hirofumi Doi

    发明人: Hirofumi Doi

    IPC分类号: H02K5/00

    CPC分类号: H02K5/00

    摘要: An electrical actuator has a DC motor which is provided with a rotor having a permanent magnet for forming a plurality of magnetic poles around a periphery thereof and a stator having a plurality of energizing coils and being disposed around a periphery of the rotor to thereby generate a rotary force for the rotor. In mounting this DC motor on a heat-generating member which generates radiant heat, a member for shielding radiant heat from a heat-generating member is disposed between the DC motor and the heat generating member. In this manner, the radiant heat from the heat-generating member is prevented from reaching the DC motor, whereby the problems in the DC motor associated with the radiant heat can be prevented.

    Device, method, and program storage medium for executing genetic algorithm
    8.
    发明授权
    Device, method, and program storage medium for executing genetic algorithm 失效
    用于执行遗传算法的设备,方法和程序存储介质

    公开(公告)号:US06182057B2

    公开(公告)日:2001-01-30

    申请号:US08990050

    申请日:1997-12-12

    IPC分类号: G06F1518

    CPC分类号: G06N3/126

    摘要: A genetic algorithm executing device, in which search of a genetic algorithm is improved, sets a distribution of characters at each position of character strings represent candidates of solution, obtain the degree of disorder at each position by the distributions of characters, set a larger mutation rate at the position of which degree of disorder is higher. This device performs a mutation operation on the character strings according to the mutation rates. This device generates the new character strings by selecting positions of which degrees of disorder are higher than a predetermined value, and changing the character at the selected positions.

    摘要翻译: 遗传算法执行装置,其中改进了遗传算法的搜索,设置了字符串每个位置处的字符分布表示解的候选,通过字符分布获得每个位置的无序程度,设置较大的突变 在无序程度较高的位置的比率。 该装置根据突变率对字符串进行突变操作。 该装置通过选择无序程度高于预定值的位置并改变所选位置的字符来生成新的字符串。

    STRUCTURE OF MOTOR TERMINAL
    9.
    发明申请
    STRUCTURE OF MOTOR TERMINAL 有权
    电机端子结构

    公开(公告)号:US20100007228A1

    公开(公告)日:2010-01-14

    申请号:US12524386

    申请日:2007-10-30

    IPC分类号: H02K11/00

    摘要: A terminal structure for a vehicle-mounted motor includes a motor body having a motor terminal 28 connected to a coil, and a circuit body 5 holding a circuit board 18 for controlling a rotation of the motor body and is assembled in the motor body, wherein a stress relaxation section 35 is provided in an intermediate of an intermediate conductor 34, in order to reduce stress acting on the intermediate conductor 34 connecting the motor terminal 28 and the circuit board 18 and to thereby improve the conductive reliability of electrical joint.

    摘要翻译: 一种用于车载电动机的端子结构,包括具有连接到线圈的电动机端子28的电动机主体和保持用于控制电动机主体的旋转并且组装在电动机主体中的电路板18的电路体5,其中 在中间导体34的中间设置有应力缓和部35,以便减小作用在连接电动机端子28和电路基板18的中间导体34上的应力,从而提高电接头的导电可靠性。

    Remedy For Melanoma
    10.
    发明申请
    Remedy For Melanoma 审中-公开
    治疗黑色素瘤

    公开(公告)号:US20070259805A1

    公开(公告)日:2007-11-08

    申请号:US11658652

    申请日:2005-08-03

    IPC分类号: A61K38/00 C12N5/06 G01N33/53

    CPC分类号: G01N33/566

    摘要: The present invention was aimed at reducing transcription activating activity of MITF-M to inhibit production of BCL2 gene product and thereby to allow treatment and/or prevention of melanoma The present invention provided a method of inhibiting production of BCL2 gene product and an agent for inhibiting the same, which inhibit binding of protein selected from a group consisting of HLF, ELK4 and CLOCK to MITF-M, a method of inducing cell death of melanoma cells, an agent for inducing the same, an agent for treating and/or preventing diseases accompanied by enhanced production of BCL2 gene product, such as melanoma, a method of treating and/or preventing the diseases, a method of identifying any one of the following compounds: a compound that inhibits the aforementioned binding; a compound that inhibits production of BCL2 gene product; and a compound that increases sensitivity of melanoma to melanoma drugs, as well as a reagent kit.

    摘要翻译: 本发明旨在降低MITF-M的转录激活活性以抑制BCL2基因产物的产生,从而能够治疗和/或预防黑素瘤本发明提供了抑制BCL2基因产物的生成和抑制作用的方法 相同的,其抑制了选自由HLF,ELK4和CLOCK组成的组的蛋白质与MITF-M的结合,诱导黑素瘤细胞的细胞死亡的方法,诱导它们的药剂,用于治疗和/或预防疾病的药剂 伴随着BCL2基因产物如黑素瘤的增强生产,治疗和/或预防疾病的方法,鉴定任何一种以下化合物的方法:抑制上述结合的化合物; 抑制BCL2基因产物生成的化合物; 以及增加黑素瘤对黑素瘤药物敏感性以及试剂盒的化合物。